Objective: to comparatively assess the weighted average costs associated with the use of alogliptin-pioglitazone combination versus glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Material and methods. A retrospective study involved pharmacoeconomic analysis. including cost-minimization analysis and budget impact analysis. https://www.lightemupsequences.com/top-offer-SALE-Skylight-Quilt-PATTERN-P173-by-Fran-Gulick-Riley-Blake-INSTRUCTIONS-Only-Confident-Beginner-Precut-Friendly-Mult-super-offer/